BioSpace News Archive

Sponsored | Cell & Gene Therapy: The road to commercial manufacturing

Together with its Körber partner companies, Werum is working on solutions that help streamline the complex cell and gene therapy workflows and enable delivery at scale of these critical, life-saving and personalized medicines.

December 11, 2018
·
2 min read
·
Mucahit Agirtmis
Business

Lonza to Establish Strategic Biomanufacturing Base in China Using GE Healthcare Solution

New biologics facility, scheduled to be operational in 2020, will provide development and manufacturing facilities from early- to late-clinical and early-commercial stages

December 11, 2018
·
5 min read
Business

Amyris and ADL Bionatur Solutions Expand Production Agreement to Meet Growing Demand

Amyris, Inc. today announced that it has executed an expanded agreement for its existing production contract with ADL Bionatur Solutions (MAB:ADL), through its fermentation division ADL Biopharma.

December 11, 2018
·
4 min read
Genoscience Pharma named EuropaBio’s Most Innovative European Biotech SME for 2018

Company receives award in healthcare category for cancer therapy in clinical development with an action on cancer stem cells

December 11, 2018
·
4 min read
BioMidwest

Big Drug Launches Have Taught Drug Companies Some Important Lessons

With the closure of another year just weeks ahead, this time of year is one that many people use to take a look behind and see what lessons were learned over the past 12 months. For the world of biopharma, it’s also important to see what lessons have been learned.

December 11, 2018
·
3 min read
·
Alex Keown
Circassia to Exercise Option for Full US Commercial Rights to COPD Treatment Tudorza® from AstraZeneca

Circassia Pharmaceuticals plc (“Circassia” or “the Company”; LSE: CIR), a specialty pharmaceutical company focused on respiratory disease, today announces it has issued a notice of option exercise to AstraZeneca to acquire the full US commercial rights to Tudorza® (aclidinium)

December 11, 2018
·
5 min read
Business

WuXi Biologics and Oxford BioTherapeutics Expand Partnership With 5 More Antibody Compounds

WuXi Biologics, a Shanghai, China-based contract research organization focused on biologics, announced it was expanding its existing collaboration and licensing deals with UK-based Oxford BioTherapeutics (OBT).

December 11, 2018
·
2 min read
·
Mark Terry
Policy

ADNEC set to host four major events in December 2018

Preparations to host Hemodialysis Congress, SIAL Middle East, International Date Palm Exhibition & IEEE Globecom Conference completed

December 11, 2018
·
3 min read
Policy

NIH to Spend $20 Million on a Search for the Development of Alternatives to Fetal Tissue

As the Trump administration has continued to show its lack of financial support of scientific research using fetal tissue, the National Institutes of Health is setting aside $20 million to fund research that could develop alternatives to the use of embryonic tissue.

December 11, 2018
·
2 min read
·
Alex Keown
Drug Development

Top 9 Really Cool Life Science Discoveries of the Year

It seems like every time we turned around this year, there was an exciting or—on a more visceral level, “Hey, that’s cool!” science story. Here’s a look at the top 9 really cool life science discoveries of the year, from outer space, to peanut allergies, to tortoise genomes.

December 11, 2018
·
6 min read
·
Mark Terry